Table 2 - uploaded by Susan Marum
Content may be subject to copyright.
Download
View publication
Results and complications of carotid artery stenting 

Results and complications of carotid artery stenting 

Source publication
Table 1 Clinical characteristics of patients with and without coronary...
Table 2 Results and complications of carotid artery stenting 
Table 3 Clinical symptoms in patients with significant coronary artery...
Images in cardiology: Hepatopulmonary syndrome as a cause of persistent hypoxaemia
Article
Full-text available
  • Dec 2005
A 38 year old man, submitted for orthotopic liver transplantation for α1 antitrypsin deficit hepatic cirrhosis, was admitted to the intensive care unit for postoperative monitoring. Ventilatory weaning was difficult because of severe hypoxaemia even using high FIo2 (Pao2 < 60 mm Hg for FIo2 of 0.7). …
Cite
Download full-text

Context in source publication

Context 1
... values of p ( 0.05 were considered significant. Table 2 shows the results of carotid artery stenting. The rates of success and neurological complications were not signifi- cantly different between patients with and patients without concomitant coronary artery disease. ...

Citations

Progress in investigating the pathogenesis of hepatopulmonary syndrome
Article
  • Aug 2010
  • HEPATOB PANCREAT DIS
The pathogenesis of hepatopulmonary syndrome is complicated and remains unknown. This review aims to provide an updated knowledge about the pathogenesis of the syndrome. Five medical databases, MEDLINE, ScienceDirect, OVID, Springer Link, and Wiley InterScience were searched for articles on "hepatopulmonary syndrome", "cirrhosis", "angiogenesis", "intestinal endotoxemia", "nitric oxide", "carbon monoxide", and other related subjects. Currently, imbalance between vasodilation and vasoconstriction, intestinal bacterial translocation, intestinal endotoxemia, and activation of the lung monocyte/macrophage system may play important roles in the pathogenesis of hepatopulmonary syndrome. Recent studies found that angiogenesis is also an important factor in the pathogenesis of experimental hepatopulmonary syndrome. Angiogenesis inhibition may be a potential approach for the treatment of hepatopulmonary syndrome in the future.
View